Filana Therapeutics, Inc.
FLNANASDAQHealthcareBiotechnology
As of Oct 23, 2026 close
- Market cap
- $30.70M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $0.67$4.42
- Volume (live)
- -
- Avg. volume (3M)
- 3.99M
Filana Therapeutics (FLNA) Stock Price & Financial Analysis
Filana Therapeutics Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $0.62 - $0.65 |
|---|---|
| 52-Week High | $4.42 |
| 52-Week Low | $0.67 |
| Open | $0.64 |
| Volume (last close) | 313.55K |
| Average Volume (3M) | 3.99M |
| 50-Day MA | $0.84 |
|---|---|
| 200-Day MA | $1.42 |
| 1-Year Change | −83.27% |
| Market Cap | 30.70M |
|---|---|
| Shares Outstanding | 48.31M |
| Price to Book (P/B) | 0.48 |
| EV/EBITDA | 1.16 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Last Dividend Ex-Date | Dec 13, 2012 |
Source: Market prices and company fundamentals. Data as of Oct 23, 2026. Data sources and methodology
Filana Therapeutics at a Glance
As of the Oct 23, 2026 close, Filana Therapeutics (FLNA) has a market capitalization of $30.70M.
As of its latest reported balance sheet, it holds $82.68M in cash and securities against $0.00 of debt, a net cash position of $82.68M.
Filana Therapeutics does not currently pay a dividend.
The share price is down 83.3% over the past year. At $0.64 (the Oct 23, 2026 close) it sits near the bottom of its 52-week range of $0.67 to $4.42, below its 200-day moving average of $1.42.
Frequently Asked Questions About Filana Therapeutics
What is the current stock price for FLNA?
As of the Oct 23, 2026 close, FLNA stock trades at $0.64. The 52-week range is $0.67–$4.42, with a day range of $0.62–$0.65.
What is the P/E ratio for FLNA?
The P/E ratio (Price-to-Earnings) for FLNA is shown in the Key Statistics section. This valuation metric helps compare Filana Therapeutics, Inc. to industry peers.
Does FLNA pay dividends?
Filana Therapeutics does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for FLNA?
Analyst ratings and recommendations for FLNA are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of FLNA?
As of the Oct 23, 2026 close, Filana Therapeutics's market capitalization is $30.7M, classifying it as a micro-cap company. Filana Therapeutics operates in the Healthcare sector within the Biotechnology industry.